• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.65% Nasdaq Down 1.89%

    Sagent Pharmaceuticals, Inc. (SGNT)

    -NasdaqGS
    26.53 0.50(1.92%) Jan 27, 4:00PM EST
    Add to Portfolio
    Prev Close:26.03
    Open:25.77
    Bid:20.25 x 200
    Ask:N/A
    1y Target Est:31.29
    Beta:1.19
    Earnings Date:Feb 9 - Feb 13 (Est.)
    Day's Range:25.77 - 26.74
    52wk Range:17.49 - 33.60
    Volume:227,906
    Avg Vol (3m):284,839
    Market Cap:846.57M
    P/E (ttm):63.62
    EPS (ttm):0.42
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    SGNTUp 1.92%846.57M
    PFE205.40B

    Key Statistics

    Forward P/E (1 yr):41.45
    P/S (ttm):3.08
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :0.32
    Quarterly EPS Est (Dec-14) :0.01
    Mean Recommendation*:2.9
    PEG Ratio (5 yr expected):1.16

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Sagent Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, sources, manufactures, and markets pharmaceutical products, principally injectable-based generic equivalents to branded products in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback